Issue: June 2016
May 28, 2016
5 min watch
Save

VIDEO: Surgeon reports 2-year data on the COMPASS trial

Issue: June 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

MILAN — At the OSN Italy meeting, E. Randy Craven, MD, discusses minimally invasive glaucoma surgery focusing on the 2-year results of the COMPASS trial on the CyPass micro-stent from Transcend Medical, as well as methods of sustained IOP reduction with an implantable drug delivery system.